IA2 has been extensively studied in human diabetic patients as it is a major autoantigen in type I diabetes, and up to 70% of newly diagnosed type I diabetes patients have autoantibodies to IA2 [54]. Here, PTPRN is linked to type 1 diabetes mellitus.